Advice
On the basis of the currently available evidence Anakinra is not recommended for use in NHS Scotland
REASONS FOR ADVICE
The company have produced no additional data to indicate a susceptible target population for this biological product which does not appear to be as effective as competitor products, and is not particularly cost effective.
Download detailed advice22KB (PDF)
Medicine details
- Medicine name:
- anakinra (Kineret)
- SMC ID:
- 05/02
- Indication:
- Rheumatoid arthritis
- Pharmaceutical company
- Amgen Ltd
- BNF chapter
- Musculoskeletal and joint diseases
- Submission type
- Resubmission
- Status
- Not recommended
- Date advice published
- 08 November 2002